send to a friend by email

JPH posts net income of $1.50 million in Q1 2023

2023-05-16

According to the financial statements of Jerusalem Pharmaceuticals Company for the 1st Quarter of 2023, Net profit after tax of the period reached 1,501,916 USD Compared with Net profit after tax 1,286,149 USD for 2022, a net increase in profit of 16.78%.Total assets of the company reached 83,818,689 USD compared with total assets of 83,723,210 USD at the end of year 2022, a net increase of 0.11%.Total liabilities of the company reached 17,479,529 USD compared with total liabilities of 18,491,908 USD at the end of year 2022, a net decrease of 5.47%. Net ownership equity of the company reached 66,339,160 USD (Including Non-Controlling Interests of 976,014 USD) compared with total owner equity of 65,231,302 USD (Including Non-Controlling Interests of 964,992 USD) at the end of year 2022, a net increase of 1.70%.